Laparoscopic Adrenalectomy for Metachronous Metastases After Ipsilateral Nephrectomy for Renal-Cell Carcinoma

被引:10
作者
Abel, E. Jason [2 ]
Karam, Jose A.
Carrasco, Alonso
Matin, Surena F. [1 ]
机构
[1] UT MD Anderson Canc Ctr, Dept Urol, Unit 1373, Houston, TX 77030 USA
[2] Univ Wisconsin, Dept Urol, Madison, WI USA
基金
美国国家卫生研究院;
关键词
RADICAL NEPHRECTOMY; LOCAL RECURRENCE; FOSSA RECURRENCE; EXPERIENCE; RESECTION; TRANSPERITONEAL;
D O I
10.1089/end.2011.0066
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and Purpose: While laparoscopic adrenalectomy (LA) is considered the standard of care for removal of small adrenal masses, there are minimal data describing the feasibility and outcomes of LA after previous ipsilateral nephrectomy (PIN). The purpose of the study was to describe the perioperative outcomes in a series of patients who were undergoing LA after PIN. Patients and Methods: Using an institutional database, we identified patients who underwent LA since 2002 by a single surgeon. Clinical and pathologic data were collected and analyzed. To evaluate outcomes, patients undergoing LA after PIN were compared with patients undergoing LA without PIN. Results: Of 54 consecutive patients undergoing LA, 8 had PIN for renal-cell carcinoma (RCC). Estimated blood loss was not significantly greater in patients with PIN: 50 mL vs 100 mL, P = 0.109. Operative time was longer in patients with PIN: 120 minutes vs 156 minutes, P = 0.015. There was no difference in length of hospital stay between groups: Median 2 days for both groups, P = 0.635. One patient in the PIN group had a conversion to open adrenalectomy and needed blood transfusion. Perioperative complications were seen in 5/46 (10.6%) patients without and in 1/8 (12.5%) patients with PIN. Surgical margins were negative in all patients. Conclusions: To the authors' knowledge, this study represents the largest experience with adrenalectomy in the reoperative setting. LA after PIN is associated with a longer operative time. While the potential for conversion is possible, it is technically feasible in selected patients and thus far appears to be associated with similar perioperative outcomes compared with patients without PIN.
引用
收藏
页码:1323 / 1327
页数:5
相关论文
共 22 条
  • [1] Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients
    Antonelli, A
    Cozzoli, A
    Simeone, C
    Zani, D
    Zanotelli, T
    Portesi, E
    Cunico, SC
    [J]. BJU INTERNATIONAL, 2006, 97 (03) : 505 - 508
  • [2] Single center preliminary experience with hand-assisted laparoscopic resection of isolated renal cell carcinoma fossa recurrences
    Bandi, Gaurav
    Wen, C. Charles
    Moon, Timothy D.
    Nakada, Stephen Y.
    [J]. UROLOGY, 2008, 71 (03) : 495 - 499
  • [3] ANALYSIS OF IMAGING MODALITIES, STAGING SYSTEMS, AND PROGNOSTIC INDICATORS FOR RENAL-CELL CARCINOMA
    DINNEY, CPN
    AWAD, SA
    GAJEWSKI, JB
    BELITSKY, P
    LANNON, SG
    MACK, FG
    MILLARD, OH
    [J]. UROLOGY, 1992, 39 (02) : 122 - 129
  • [4] Duh QY, 1996, ARCH SURG-CHICAGO, V131, P870
  • [5] Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma
    Eggener, Scott E.
    Yossepowitch, Ofer
    Kundu, Shilajit
    Motzer, Robert J.
    Russo, Paul
    [J]. JOURNAL OF UROLOGY, 2008, 180 (03) : 873 - 878
  • [6] Renal cell carcinoma recurrence after nephrectomy for localized disease: Predicting survival from time of recurrence
    Eggener, Scott E.
    Yossepowitch, Ofer
    Pettus, Joseph A.
    Snyder, Mark E.
    Motzer, Robert J.
    Russo, Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3101 - 3106
  • [7] Isolated local recurrence of renal cell carcinoma after radical nephrectomy:: Experience with 10 cases
    Gögüs, Ç
    Baltaci, S
    Bedük, Y
    Sahinli, S
    Küpeli, S
    Gögüs, O
    [J]. UROLOGY, 2003, 61 (05) : 926 - 929
  • [8] Imaging in metastatic renal cell carcinoma
    Griffin, Nyree
    Gore, Martin E.
    Sohaib, S. Aslam
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 189 (02) : 360 - 370
  • [9] Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study
    Heng, Daniel Y. C.
    Xie, Wanling
    Regan, Meredith M.
    Warren, Mark A.
    Golshayan, Ali Reza
    Sahi, Chakshu
    Eigl, Bernhard J.
    Ruether, J. Dean
    Cheng, Tina
    North, Scott
    Venner, Peter
    Knox, Jennifer J.
    Chi, Kim N.
    Kollmannsberger, Christian
    McDermott, David F.
    Oh, William K.
    Atkins, Michael B.
    Bukowski, Ronald M.
    Rini, Brian I.
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) : 5794 - 5799
  • [10] Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy
    Itano, NB
    Blute, ML
    Spotts, B
    Zincke, H
    [J]. JOURNAL OF UROLOGY, 2000, 164 (02) : 322 - 325